| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.3 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |